Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 6;25(1):270.
doi: 10.1186/s12886-025-04050-7.

Correlation among ocular surface changes and systemic hematologic indexes and disease activity in primary Sjögren's syndrome: a cross-sectional study

Affiliations

Correlation among ocular surface changes and systemic hematologic indexes and disease activity in primary Sjögren's syndrome: a cross-sectional study

Yan He et al. BMC Ophthalmol. .

Abstract

Background: To explore the relationship among ocular surface changes, systemic hematologic indexes, and disease activity in primary Sjögren's syndrome patients.

Methods: Thirty-three primary Sjögren's syndrome patients and 36 healthy controls were recruited in this cross-sectional study. All participants underwent complete ocular surface testing, including dry eye symptoms and signs, tear multi-cytokine analysis, and conjunctival impression cytology (CIC). Multiple systemic hematologic indexes and disease activity were also evaluated, including autoantibodies, immune cells, the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI), and the EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI).

Results: Primary Sjögren's syndrome patients exhibited significant dry eye, severe conjunctivochalasis, decreased goblet cell density, and severe squamous epithelial on the ocular surface. Interferon-inducible T cell alpha chemoattractant (I-TAC), granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-1β, IL-5, IL-8, IL-10, IL-13, IL-21, C-C motif chemokine ligand (CCL)4, interferon-gamma (IFN-γ), CCL20, and tumor necrosis factor-gamma (TNF-α) in the tear fluid of pSS patients changed significantly. Correlation analysis showed that anti-SSA was relevant to ocular surface disease index (OSDI) score, tear break-up time (TBUT), and meibomian gland secretion (MGS). CD8+ T cell percentages were relevant to TBUT and corneal fluorescein staining score (CFS). IL-8, IL-13, CCL4, and TNF-α were correlated with RF-IgA. IL-1β, CCL4, and TNF-α were correlated with CD8+ T cell counts. IL-5 and CCL20 were correlated with the ratio of helper T cells and suppressor T cells. Tear I-TAC, IL-8, CCL20, and TNF-α were significantly correlated with the ESSDAI of different domains.

Conclusions: Our results revealed that the ocular surface changes in pSS patients were significantly correlated with systemic hematologic indexes and disease activity.

Keywords: Disease activity; Dry eye; Primary Sjögren’s syndrome; Tear cytokines.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: All subjects participated in the program voluntarily and signed informed consent forms. The study obtained written informed consent from all enrolled patients, approved by the Ethics Committee of The Second Xiangya Hospital of Central South University (Ethics code, LYF2021028). This study strictly followed the Helsinki declaration, which was implemented to in ensuring the rights and safety of the subjects. Consent for publication: All authors read and approved the final manuscript before submission. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Conjunctival impression cytology specimens. (A) Representative specimen of pSS patients. Goblet cells were less numerous, epithelial cells were enlarged and showed an abnormal appearance of squamous metaplasia with small and pyknotic nuclei. (B) Representative specimen from healthy controls. Goblet cells were abundant, and epithelial cells were small, round, and evenly distributed. Arrowheads indicate goblet cells. (Scale bar = 50 μm)

Similar articles

Cited by

References

    1. Mavragani CP, Moutsopoulos HM. Sjogren’s syndrome: old and new therapeutic targets. J Autoimmun. 2020;110:102364. 10.1016/j.jaut.2019.102364 - PubMed
    1. Bowman SJ. Primary Sjögren’s syndrome. Lupus. 2018;27(1suppl):32–5. 10.1177/0961203318801673 - PubMed
    1. Akpek EK, Mathews P, Hahn S, Hessen M, Kim J, Grader-Beck T, et al. Ocular and systemic morbidity in a longitudinal cohort of Sjögren’s syndrome. Ophthalmology. 2015;122(1):56–61. 10.1016/j.ophtha.2014.07.026 - PubMed
    1. Murube J. Primary and secondary Sjogren-Jones Syndromes—Historical evolution. Ocul Surf. 2011;9(1):13–. 10.1016/s1542-0124(11)70005-2. 6. - PubMed
    1. Foulks GN, Forstot SL, Donshik PC, Forstot JZ, Goldstein MH, Lemp MA, et al. Clinical guidelines for management of dry eye associated with Sjogren disease. Ocul Surf. 2015;13(2):118–32. 10.1016/j.jtos.2014.12.001 - PubMed